These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 55556)

  • 21. Clofibrate-induced myopathy and neuropathy.
    Gabriel R; Pearce JM
    Lancet; 1976 Oct; 2(7991):906. PubMed ID: 62135
    [No Abstract]   [Full Text] [Related]  

  • 22. Muscle syndrome with clofibrate usage.
    Kra SJ
    Conn Med; 1974 Jul; 38(7):348-9. PubMed ID: 4845133
    [No Abstract]   [Full Text] [Related]  

  • 23. Clofibrate-induced acute muscular syndrome.
    Sekowski I; Samuel P
    Am J Cardiol; 1972 Oct; 30(5):572-4. PubMed ID: 5073673
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clofibrate-induced muscle problems].
    Bojs G; Fahlén M; Lapidus L
    Lakartidningen; 1979 Jul; 76(30-31):2631-2. PubMed ID: 529902
    [No Abstract]   [Full Text] [Related]  

  • 25. [The question of adverse effects of clofibrate. Experience in patients with diabetes mellitus].
    Häser C; Rahlfs V; Mehnert H
    Ther Ggw; 1976 Aug; 115(8):1382-95. PubMed ID: 793084
    [No Abstract]   [Full Text] [Related]  

  • 26. [Changes in lipid metabolism in a case of associated primary hypothyroidism, obesity and diabetes mellitus].
    Pagliano FM; Bombara R; Giraldi B; Visca U
    Minerva Med; 1976 Jul; 67(35):2294-300. PubMed ID: 821020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Creatinekinase in hyperlipoproteinemic patients treated with clofibrate.
    Schneider J; Mühlfellner G; Kaffarnik H
    Artery; 1980; 8(2):164-70. PubMed ID: 7458683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clofibrate treatment of hyperlipidemia in long-term dialysis patients].
    Wessels G; Müller H; Busch G; Loew H
    Med Welt; 1976 Nov; 27(47):2278-9. PubMed ID: 826753
    [No Abstract]   [Full Text] [Related]  

  • 29. Gemfibrozil-induced myopathy.
    Magarian GJ; Lucas LM; Colley C
    Arch Intern Med; 1991 Sep; 151(9):1873-4. PubMed ID: 1888257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tolerability and side-effects of bis-(hydroxy-2-ethylthio)-1,10-decane (BS 530) as compared with clofibrate in the therapy of hyperlipemia].
    Colombo L; Monarca A; Goldberg D; Zanetta R
    Clin Ter; 1979 Oct; 91(2):155-71. PubMed ID: 540479
    [No Abstract]   [Full Text] [Related]  

  • 31. Clofibrate treatment of neonatal jaundice.
    Erkul I; Yavuz H; Ozel A
    Pediatrics; 1991 Dec; 88(6):1292-4. PubMed ID: 1956756
    [No Abstract]   [Full Text] [Related]  

  • 32. [Atypical muscular syndrome with myolysis during long-term treatment with fibrates].
    Chauvin M; Zupan M; Brechenmacher C
    Arch Mal Coeur Vaiss; 1988 Jul; 81(7):921-3. PubMed ID: 3142389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of hyperlipemia with clofibrate in a case of nephrotic syndrome: secondary enzymatic and muscular alterations].
    Fabre J; Denizot M; Giromini M; Micheli H
    J Urol Nephrol (Paris); 1973; 79(4):381-3. PubMed ID: 4720134
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clofibrate in the treatment of diabetes mellitus].
    Bornemisza P; Csögör I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978; 30(4):359-62. PubMed ID: 30153
    [No Abstract]   [Full Text] [Related]  

  • 35. Letter: Clofibrate treatment of diabetes insipidus.
    Suha E
    JAMA; 1974 Apr; 228(5):567. PubMed ID: 4406179
    [No Abstract]   [Full Text] [Related]  

  • 36. Clofibrate and diabetes control in patients treated with oral hypoglycaemic agents.
    Daubresse JC; Daigneux D; Bruwier M; Luyckx A; Lefebvre PJ
    Br J Clin Pharmacol; 1979 Jun; 7(6):599-603. PubMed ID: 380614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interference of clofibrate in metabolic compensation in dyslipidemic diabetics].
    Gatti A; Carletta C
    Clin Ter; 1979 Oct; 91(1):57-65. PubMed ID: 397871
    [No Abstract]   [Full Text] [Related]  

  • 38. [Current data on adverse effects of clofibrate].
    Wójcicki J
    Pol Tyg Lek; 1980 Jan; 35(1):21-3. PubMed ID: 7367314
    [No Abstract]   [Full Text] [Related]  

  • 39. [Gemfibrozil-induced myopathy].
    Aron A; Adler Y; Weiss P
    Harefuah; 1993 Nov; 125(9):270-1, 327. PubMed ID: 8253419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Letter: Clofibrate-induced antinuclear factor and lupus-like syndrome.
    Howard EJ; Brown SM
    JAMA; 1973 Dec; 226(11):1358-9. PubMed ID: 4543329
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.